# Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects

> **NCT05005455** · PHASE1 · COMPLETED · sponsor: **Innovent Biologics (Suzhou) Co. Ltd.** · enrollment: 100 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** bevacizumab with new manufacturing process.
- **DRUG:** bevacizumab with old manufacturing process.

## Key facts

- **NCT ID:** NCT05005455
- **Lead sponsor:** Innovent Biologics (Suzhou) Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-30
- **Primary completion:** 2022-01-28
- **Final completion:** 2022-01-28
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05005455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05005455, "Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT05005455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*